Anti-GPX8 monoclonal antibody

Pre-made anti-GPX8 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GPX8/GPX8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0943-Ab-1/ GM-Tg-hg-IP0943-Ab-2Anti-Human GPX8 monoclonal antibodyHuman
GM-Tg-rg-IP0943-Ab-1/ GM-Tg-rg-IP0943-Ab-2Anti-Rat GPX8 monoclonal antibodyRat
GM-Tg-mg-IP0943-Ab-1/ GM-Tg-mg-IP0943-Ab-2Anti-Mouse GPX8 monoclonal antibodyMouse
GM-Tg-cynog-IP0943-Ab-1/ GM-Tg-cynog-IP0943-Ab-2Anti-Cynomolgus/ Rhesus macaque GPX8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0943-Ab-1/ GM-Tg-felg-IP0943-Ab-2Anti-Feline GPX8 monoclonal antibodyFeline
GM-Tg-cang-IP0943-Ab-1/ GM-Tg-cang-IP0943-Ab-2Anti-Canine GPX8 monoclonal antibodyCanine
GM-Tg-bovg-IP0943-Ab-1/ GM-Tg-bovg-IP0943-Ab-2Anti-Bovine GPX8 monoclonal antibodyBovine
GM-Tg-equg-IP0943-Ab-1/ GM-Tg-equg-IP0943-Ab-2Anti-Equine GPX8 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0943-Ab-1/ GM-Tg-hg-IP0943-Ab-2; GM-Tg-rg-IP0943-Ab-1/ GM-Tg-rg-IP0943-Ab-2;
GM-Tg-mg-IP0943-Ab-1/ GM-Tg-mg-IP0943-Ab-2; GM-Tg-cynog-IP0943-Ab-1/ GM-Tg-cynog-IP0943-Ab-2;
GM-Tg-felg-IP0943-Ab-1/ GM-Tg-felg-IP0943-Ab-2; GM-Tg-cang-IP0943-Ab-1/ GM-Tg-cang-IP0943-Ab-2;
GM-Tg-bovg-IP0943-Ab-1/ GM-Tg-bovg-IP0943-Ab-2; GM-Tg-equg-IP0943-Ab-1/ GM-Tg-equg-IP0943-Ab-2
Products NameAnti-GPX8 monoclonal antibody
Formatmab
Target NameGPX8
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GPX8 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0943-Ag-1Recombinant multi-species GPX8/ EPLA847/ GPx-8 protein


    Target information

    Target IDGM-IP0943
    Target NameGPX8
    Gene ID493869,69590,294744,705965,478059,101087197,511575,100052064
    Gene Symbol and Synonyms2310016C16Rik,EPLA847,GPx-8,GPX8,GSHPx-8,RGD1307506,UNQ847
    Uniprot AccessionQ8TED1,Q2NL01
    Uniprot Entry NameGPX8_HUMAN,GPX8_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000164294
    Target ClassificationN/A

    The target: GPX8, gene name: GPX8, also named as EPLA847, GPx-8, GSHPx-8, UNQ847. Enables peroxidase activity. Predicted to be involved in cellular response to oxidative stress. Predicted to be located in endoplasmic reticulum lumen. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.